Provided by Tiger Fintech (Singapore) Pte. Ltd.

BriaCell Therapeutics Corp.

3.84
+0.390011.30%
Post-market: 3.840.00000.00%19:26 EDT
Volume:62.14K
Turnover:230.54K
Market Cap:14.24M
PE:-0.29
High:3.89
Open:3.73
Low:3.45
Close:3.45
Loading ...

BriaCell Announces Completion of 15:1 Share Consolidation

GlobeNewswire
·
28 Jan

BriaCell Plans Share Consolidation for Nasdaq Compliance

TIPRANKS
·
04 Jan

BriaCell Announces Rescheduling of its Annual General Meeting of Shareholders to February 5, 2025

GlobeNewswire
·
04 Jan

BriaCell Announces Proposed Effective Date of Share Consolidation

GlobeNewswire
·
04 Jan

Insider Purchases Worth US$5.52m See Losses As BriaCell Therapeutics Market Value Drops To CA$40m

Simply Wall St.
·
19 Dec 2024

BriaCell Adapts Meeting Procedures Amid Postal Strike

TIPRANKS
·
18 Dec 2024

Briacell Therapeutics Corp reports results for the quarter ended October 31 - Earnings Summary

Reuters
·
17 Dec 2024

BriaCell Therapeutics Reports Quarterly Financial Loss

TIPRANKS
·
17 Dec 2024

BriaCell Therapeutics Closes $5.5 Million Offering

TIPRANKS
·
14 Dec 2024

BriaCell 2024 SABCS® Poster Highlights Ability of Bria-IMT™ Regimen to Increase Cancer-Fighting Immune Cells in Metastatic Breast Cancer

GlobeNewswire
·
13 Dec 2024

BRIEF-Briacell Therapeutics Prices Public Offering Of 7.4 Mln Shares And Warrants At $0.75 Each

Reuters
·
12 Dec 2024

BriaCell Therapeutics Announces Pricing of $5.5 Million Public Offering

GlobeNewswire
·
12 Dec 2024

BriaCell Therapeutics Plans Public Offering

TIPRANKS
·
12 Dec 2024

BriaCell announces common shares, warrants offering

TIPRANKS
·
12 Dec 2024

Briacell Therapeutics Corp expected to post a loss of 8 cents a share - Earnings Preview

Reuters
·
11 Dec 2024

BriaCell Receives Green-Light from Data Safety Monitoring Board for its Phase 3 Study in Metastatic Breast Cancer

GlobeNewswire
·
02 Dec 2024